BLACK WEEKSFlakonai −15% · rinkiniai −10% · kita −5%su koduNemokamas siuntimas Vokietijoje nuo €200

Šis puslapis išverstas automatiškai ir jame gali būti klaidų. Ar lietuvių kalba yra jūsų gimtoji? Mielai sulauksime jūsų atsiliepimų ir pataisymų.Siųsti atsiliepimą

The Peptide Desk The Peptide Desk
T4 (Levothyroxin), produkto nuotrauka

Laboratorijos ataskaita

PDF
Ištirta
Ištirta
T4 (Levothyroxin) 40mcg × 100 Tabs
Laboratorija
Analiza Białek
Data
October 2026
Rezultatas
42.40 mcg per tablet (40 mcg label)
Užsakymo nr.
Slaptažodis

Ištirta nepriklausomai, su slaptažodžiu galima patikrinti tiesiogiai laboratorijoje.

Cutting

T4 (Levothyroxin)

Cutting

Užsakymas

Vieneto kaina - Nemokamas siuntimas Vokietijoje nuo 200 € Black Weeks metu
  • DHL su sekimu
  • Diskreti pakuotė

4.6 iš 5 TrustpilotAtsiliepimų: 73

Trumpai

T4 (Levothyroxin) skaičiais

Pagrindiniai rodikliai iš mūsų žinyno. Vilkite tašką kreive, kad pamatytumėte, kiek lieka po vienos dozės, pagal skaičiavimą.

Visas žinyno įrašas

How long does it stay in the body?

Share left after one dose, calculated with a half-life of ~7 days

Half-life ~7 days
After 14 days: 25 %
Day 750 %Day 1425 %Day 2112.5 %Day 353.1 %

Simplified model without an absorption phase, half-life from the TPD lexicon.

Half-life

Approximately7days

Class
Thyroid hormoneL-thyroxine
Use
Hypothyroidism replacement therapythyroid cancer TSH suppression
Sizes
40 to 100 mcg3 sizes in the shop

Žinios

Viskas apie T4 (Levothyroxin)

FAQ

Dažnai užduodami klausimai

Šaltiniai kiekvienam atsakymui: žinyno įrašas

Dar turite klausimų?

Parašykite mums, mūsų komanda jums padės.

Is levothyroxine approved?

Yes. ChEMBL lists levothyroxine with phase 4 as the highest phase and first approval in 1982. ClinicalTrials.gov lists 338 trials with levothyroxine, as of 26 October 2026.

What did the TRUST trial show?

737 people aged 65 or older with subclinical hypothyroidism received levothyroxine or placebo. After 1 year TSH was 3.63 instead of 5.48 mIU/l. Symptoms and tiredness did not differ. The secondary outcomes showed no benefit either.

Why did patients after thyroid cancer need more?

For a normal TSH about 29 percent more per kg body weight was needed than in benign hypothyroidism. The authors explain this by residual tissue that often still makes hormone in benign hypothyroidism.

What does the meta-analysis show?

25 trials with 1,735 patients were included. Compared with placebo levothyroxine raised FT4 and lowered TSH. In subclinical hypothyroidism systolic blood pressure fell too. T4 together with T3 lowered TSH more and raised FT3 compared with T4 alone.

Does a combination with T3 help?

According to a review, trials of the combination showed no superiority over T4 alone. For a small group who do not feel well on T4, guidelines consider a supervised trial possible. Several trials on this are still running.

What about pregnancy?

In two trials with 677 and 526 pregnant women treating mild hypothyroidism did not improve the children's IQ at age 5. Adverse events were rare in both groups.

Palyginimai

Kuo skiriasi

Susiję

Susiję produktai